XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 2 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

2
Player Avatar BrianRuth (99.11) Submitted: 3/5/2007 2:16:43 AM : Underperform Start Price: $45.90 XOMA Score: +144.40

Calling BS on this one. It would be great if they could help cancer with recombinant whatever, but I think 9 out of 10 microcap companies in this space will go bankrupt.

Member Avatar talon444 (< 20) Submitted: 9/14/2007 9:57:00 PM
Recs: 1

Ya most will probably go bankrupt eventually. XOMA might. On the other hand this is not garage company praying for a make-or-break miracle drug to keep them afloat. They have had several legit successes that they are collecting royalties on from some of the bigger names. Would not recommend anyone buy these small cap biopharm stocks for a "safe" play. If you want to be speculative though and have a large upside potential this is a nice stock with a huge upside.

Featured Broker Partners


Advertisement